Somanta Pharmaceuticals Inc.
SEC CIK 888671 · SMPM.OB · last insider filing 2008-01-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Jeffrey B Davis | Director | filed 2006 - 2008 |
| Ashton Michael | Director | filed 2006 - 2006 |
| VAN Sleen Kathleen H | Director | filed 2006 - 2006 |
| Davis Jeffrey B | Director | filed 2006 - 2006 |
| Gibson John Robin | Director | filed 2006 - 2006 |
| Bruggeman Terrance J | Director · Executive Chairman | filed 2006 - 2006 |
| Epenetos Agamemnon A | Director · Chief Executive Officer | filed 2006 - 2006 |
| Gibson John R | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kramer David W | Chief Financial Officer | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.